INTS9 | Integrator complex subunit 9 | | | | | | Expressed in all |
HMBOX1 | Homeobox containing 1 | Transcription factors
| | | | | Expressed in all |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
DCTN6 | Dynactin 6 | | | | | | Expressed in all |
RBPMS | RNA binding protein with multiple splicing | | | | | | Expressed in all |
GTF2E2 | General transcription factor IIE, polypeptide 2, beta 34kDa | | | | | | Expressed in all |
SMIM18 | Small integral membrane protein 18 | Predicted membrane proteins
| | | | | Tissue enriched |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
TEX15 | Testis expressed 15 | | | | | | Group enriched |
WRN | Werner syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TTI2 | TELO2 interacting protein 2 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MAK16 | MAK16 homolog (S. cerevisiae) | | | | | | Expressed in all |
ERLIN2 | ER lipid raft associated 2 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
PROSC | Proline synthetase co-transcribed homolog (bacterial) | | | | | | Expressed in all |
BRF2 | BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit | | | | | | Expressed in all |
RAB11FIP1 | RAB11 family interacting protein 1 (class I) | | | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins
| | | | | Tissue enriched |
LSM1 | LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) | | | | | | Expressed in all |
BAG4 | BCL2-associated athanogene 4 | | | | | | Expressed in all |
DDHD2 | DDHD domain containing 2 | Disease related genes
| | | | | Expressed in all |
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KAT6A | K(lysine) acetyltransferase 6A | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AP3M2 | Adaptor-related protein complex 3, mu 2 subunit | | | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
POLB | Polymerase (DNA directed), beta | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
VDAC3 | Voltage-dependent anion channel 3 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
SLC20A2 | Solute carrier family 20 (phosphate transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RNF170 | Ring finger protein 170 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
HOOK3 | Hook microtubule-tethering protein 3 | Cancer-related genes
| | | | | Expressed in all |
HGSNAT | Heparan-alpha-glucosaminide N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SPIDR | Scaffolding protein involved in DNA repair | | | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM4 | Minichromosome maintenance complex component 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
SNAI2 | Snail family zinc finger 2 | Disease related genes Transcription factors
| | | | | Mixed |
RB1CC1 | RB1-inducible coiled-coil 1 | | | | | | Expressed in all |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H | Transporters
| | | | | Expressed in all |
TCEA1 | Transcription elongation factor A (SII), 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MRPL15 | Mitochondrial ribosomal protein L15 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
TGS1 | Trimethylguanosine synthase 1 | | | | | | Expressed in all |
LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
RPS20 | Ribosomal protein S20 | Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
IMPAD1 | Inositol monophosphatase domain containing 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
FAM110B | Family with sequence similarity 110, member B | | | | | | Tissue enhanced |
SDCBP | Syndecan binding protein (syntenin) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |